Understand BL, BLA has 1 year delay if submitted by December. 10 months on FDA, 2 months on CYDY. A lot of frustration with NP over-promising September and having to dial that back. As I have said he need to manage expectations better. I suspect they thought 525mg would be the dose, maybe even got that primarily through FDA. But lots of good-will lost with that delays Using shares + warrants to continue to fund operations during the delay have taken toll also; I understand Now we know the 700mg situation, if he doesn't delivery again by end of year BLA shareholders will revolt. Fixing the financial situation would go a long way to bring some of that good will back. They brought in Brendan Rae, he got a great deal with Samsung. It looks like he is getting great terms on these partnership negotiations as well. I'm expecting that done by the BLA submission also, using paulson beyond that would probably get the a similar shareholders revolting response. I'm expecting both done by end of year or NP may not survive another delay while continuing to use shares to fund operations. At this point I have no concerns those two items getting done. With mono pivotal approval or partnership announcement next month, I'm expecting the sentiment to change. The share price moving above 40c would greatly help also.